Highest-materiality recent filing
Amesite raises $2.6M upfront in offerings; up to $6M including warrants
Gross proceeds: ~$2M from institutional registered direct & private placement.
Amesite reports 69% QoQ revenue growth in Q2 2026, plans AI-powered EMR launch
Q2 2026 revenue rose 69% QoQ; operating expenses cut.
Notified by Nasdaq on Oct 28, 2025 for non-compliance with Listing Rule 5550(b)(1) requiring $2.5M in stockholders' equity.
Amesite Q3 revenue up 2.4x sequentially; user growth 1,340% in paid subscription launch quarter
Revenue increased 2.4x from Q2 to Q3, driven by NurseMagic app, with even B2B/B2C split.
Amesite closes $3.6M best-efforts offering; regains Nasdaq equity compliance
Sold 1,201,667 shares at $3.00 each, gross proceeds $3.6M, net ~$3.08M.
Amesite (AMST) receives Nasdaq delisting notice for failure to meet $2.5M stockholders' equity rule
Received Nasdaq deficiency letter on Nov 26, 2024 for non-compliance with Listing Rule 5550(b)(1) requiring $2.5M stockholders' equity.
Amesite presents corporate update; $3.7M cash, no debt, 6 new higher-ed deals since pivot
Cash and equivalents of $3.7M, zero debt; average monthly burn projected at $297K over next 12 months.
Amesite regains Nasdaq minimum bid price compliance, removes delisting risk
Nasdaq confirmed Amesite regained compliance with $1.00 minimum bid price on March 7, 2023 after 10 consecutive trading days.
Amesite stockholders approve reverse stock split; equity plan amendment fails
Reverse stock split authorized at ratio between 1:5 and 1:50, board to set exact ratio within one year.
Amesite effects 1-for-12 reverse stock split to meet Nasdaq bid price; equity plan expanded
Reverse stock split at 1-for-12 ratio effective pre-market Feb 22, 2023; post-split shares ~2.53M.
Amesite dismisses Deloitte as auditor, appoints Turner Stone; going concern emphasis in prior audit
On Jan 27, 2023, Amesite dismissed Deloitte & Touche as its independent auditor and appointed Turner, Stone & Company.
Amesite appoints Sherlyn Farrell as CFO, replacing Mark Corrao
Sherlyn Farrell, age 60, appointed CFO effective December 15, 2022, succeeding Mark Corrao whose engagement was not renewed.
Amesite announces five new HBCUs join NAFEO alliance; COE fundraising target $30M
Five universities (Alabama State, Allen, Benedict, Clark Atlanta, Univ of DC) join NAFEO's Center for Opportunity and Equity.
Amesite raises $2.3M in registered direct offering and private placement of warrants
Gross proceeds of $2.3M from sale of 4,181,821 common shares and warrants to purchase 4,181,821 shares at combined price $0.55.
3-year MSA with NAFEO to provide LCE platform for HBCUs; auto-renews for successive 3-year terms.
Amesite receives Nasdaq bid price non-compliance notice; launches CUNY professional learning portal
Received Nasdaq deficiency letter on March 8, 2022 for failure to maintain $1.00 minimum bid price over 30 consecutive business days.
Amesite closes public offering of 3.75M shares at $0.80, raising $3M gross / $2.58M net
Priced best-efforts offering of 3,437,500 shares at $0.80/share on Feb 11; size increased to 3,750,000 on Feb 14.
authorized and approved the appointment of Sarah Berman as Principal Financial and Accounting Officer of the Company effective December 15, 2024.
the Board determined not to renew the engagement of Sherlyn W. Farrell, who previously served as the Company’s Chief Financial Officer since December 15, 2022.
On December 9, 2022, the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the appointment of Sherlyn W. Farrell, age 60, as Chief Financial Officer of the Company effective December 15, 2022.
the Board determined not to renew the engagement of Mark Corrao, who previously served as the Company’s Chief Financial Officer since December 15, 2021 for a term of one year in accordance with the CFO Agreement between the Company and Mr. Corrao.
On December 15, 2021 (the “Effective Date”), the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the termination of Matthew Kern as Chief Financial Officer of the Company, effective as of the Effective Date.
In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.
Max materiality 0.75 · Median 0.50 · Most common event other_material